U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C10H8N4O5
Molecular Weight 264.1943
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 2
Charge 0

SHOW SMILES / InChI
Structure of FURAZIDINE

SMILES

[O-][N+](=O)C1=CC=C(O1)\C=C\C=N\N2CC(=O)NC2=O

InChI

InChIKey=DECBQELQORZLLP-UAIOPKHMSA-N
InChI=1S/C10H8N4O5/c15-8-6-13(10(16)12-8)11-5-1-2-7-3-4-9(19-7)14(17)18/h1-5H,6H2,(H,12,15,16)/b2-1+,11-5+

HIDE SMILES / InChI

Molecular Formula C10H8N4O5
Molecular Weight 264.1943
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 2
Optical Activity NONE

Furagin (Furazidine) is a nitrofuran derivative, acting as an antibacterial medicine with bacteriostatic action. It is active against both gram-positive (Staphylococcus epidermidis, Staphylococcus aureus, Staphylococcus faecalis) and gram-negative microorganisms (Enterobacteriaceae – Salmonella, Shygella, Proteus, Klebsiella, Escherichia, Enterobacter, etc.). It is used for the treatment of urinary tract, skin and soft tissues infections.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Furagin

Approved Use

Furagin (Furazidine) is indicated for the treatment of urinary tract infections. Topical furagin is used in the treatment of infections of the skin and soft tissues.
Curative
Furagin

Approved Use

Furagin (Furazidine) is indicated for the treatment of urinary tract infections. Topical furagin is used in the treatment of infections of the skin and soft tissues.
PubMed

PubMed

TitleDatePubMed
Ciprofloxacin and furagin in acute cystitis: comparison of early immune and microbiological results.
2008-02
Pharmacokinetics of furagin, a new nitrofurantoin congener, on human volunteers.
1979-06
[Experimental studies on a new chemotherapeutic preparation furazidin].
1958-07
Patents

Sample Use Guides

Adults: 50-100 mg t.i.d., for 7-14 days. 0.5% or 1% solution for topical applications.
Route of Administration: Other
Furagin (Furazidine) is a broad-spectrum antimicrobial agent belonging to the group of nitrofurans. Against the majority of bacteria, the bacteriostatic concentration ranges from 1: 100,000 to 1: 200,000; bactericidal - about 2 times more.
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:08:21 GMT 2025
Edited
by admin
on Mon Mar 31 19:08:21 GMT 2025
Record UNII
K2R4N34Y9I
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FURAZIDIN
MART.  
Preferred Name English
FURAZIDINE
Common Name English
1-(((E)-3-(5-NITROFURAN-2-YL)PROP-2-ENYLIDENE)AMINO)IMIDAZOLIDINE-2,4-DIONE
Systematic Name English
AKRITOIN
WHO-DD  
Common Name English
Furazidin [WHO-DD]
Common Name English
1-((3-(5-NITRO-2-FURYL)ALLYLIDENE)AMINO)HYDANTOIN
Systematic Name English
FURAZIDIN [MART.]
Common Name English
FURAGINUM
Brand Name English
FURAGIN
Brand Name English
Classification Tree Code System Code
WHO-ATC J01XE03
Created by admin on Mon Mar 31 19:08:21 GMT 2025 , Edited by admin on Mon Mar 31 19:08:21 GMT 2025
Code System Code Type Description
MESH
D005661
Created by admin on Mon Mar 31 19:08:21 GMT 2025 , Edited by admin on Mon Mar 31 19:08:21 GMT 2025
PRIMARY
EPA CompTox
DTXSID101030908
Created by admin on Mon Mar 31 19:08:21 GMT 2025 , Edited by admin on Mon Mar 31 19:08:21 GMT 2025
PRIMARY
FDA UNII
K2R4N34Y9I
Created by admin on Mon Mar 31 19:08:21 GMT 2025 , Edited by admin on Mon Mar 31 19:08:21 GMT 2025
PRIMARY
SMS_ID
100000078582
Created by admin on Mon Mar 31 19:08:21 GMT 2025 , Edited by admin on Mon Mar 31 19:08:21 GMT 2025
PRIMARY
DRUG BANK
DB13475
Created by admin on Mon Mar 31 19:08:21 GMT 2025 , Edited by admin on Mon Mar 31 19:08:21 GMT 2025
PRIMARY
CAS
1672-88-4
Created by admin on Mon Mar 31 19:08:21 GMT 2025 , Edited by admin on Mon Mar 31 19:08:21 GMT 2025
PRIMARY
EVMPD
SUB16433MIG
Created by admin on Mon Mar 31 19:08:21 GMT 2025 , Edited by admin on Mon Mar 31 19:08:21 GMT 2025
PRIMARY
ChEMBL
CHEMBL3707254
Created by admin on Mon Mar 31 19:08:21 GMT 2025 , Edited by admin on Mon Mar 31 19:08:21 GMT 2025
PRIMARY
DRUG CENTRAL
4869
Created by admin on Mon Mar 31 19:08:21 GMT 2025 , Edited by admin on Mon Mar 31 19:08:21 GMT 2025
PRIMARY
PUBCHEM
6870646
Created by admin on Mon Mar 31 19:08:21 GMT 2025 , Edited by admin on Mon Mar 31 19:08:21 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY